Related Experiment Videos
Abnormal chemotaxis in patients with cutaneous anergy
Mayo Clinic Proceedings
|March 1, 1977
Summary
Patients with persistent cutaneous anergy may have combined leukocyte function defects. This impacts their immune response, potentially explaining their anergy.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Persistent cutaneous anergy is a clinical sign of impaired immune function.
- Understanding the underlying cellular mechanisms is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate leukocyte function in patients with persistent cutaneous anergy.
- To identify potential defects in chemotaxis and immune factor production.
Main Methods:
- Studied chemotaxis of polymorphonuclear leukocytes and mononuclear leukocytes in six patients.
- Assessed lymphocyte-derived chemotactic factor production in vitro.
- Compared responses to normal chemotactic factors against controls.
Main Results:
- Patients exhibited a combined defect in leukocyte function.
- Impaired production of lymphocyte-derived chemotactic factor by lymphocytes.
- Reduced response of polymorphonuclear and mononuclear leukocytes to chemotactic factors.
Conclusions:
- Persistent cutaneous anergy can be associated with combined leukocyte functional defects.
- Abnormal mononuclear leukocyte chemotaxis may contribute to persistent cutaneous anergy.